id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2016-0020-0008,DEA,DEA-2016-0020,"Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I",Proposed Rule,,2019-04-08T04:00:00Z,2019,4,2019-04-08T04:00:00Z,2019-05-09T03:59:59Z,2019-05-09T01:01:30Z,2019-06853,0,0,0900006483b716a9
DEA-2016-0020-0007,DEA,DEA-2016-0020,"Schedules of Controlled Substances: Extension of Temporary Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I of the Controlled Substances Act",Rule,,2019-04-08T04:00:00Z,2019,4,,,2019-04-08T12:50:07Z,2019-06851,0,0,0900006483b715e1
DEA-2016-0020-0009,DEA,DEA-2016-0020,Six Synthetic Cannabinoids 8 Factor,Supporting & Related Material,,2019-04-08T04:00:00Z,2019,4,,,2019-04-08T13:08:49Z,,0,0,0900006483b7188c
DEA-2016-0020-0011,DEA,DEA-2016-0020,6SCs 8Factor for Permanent Control 03292019,Supporting & Related Material,,2019-04-08T04:00:00Z,2019,4,,,2019-04-08T13:14:59Z,,0,0,0900006483b714e7
DEA-2016-0020-0010,DEA,DEA-2016-0020,FINAL SIGNED HHS Leter,Supporting & Related Material,,2019-04-08T04:00:00Z,2019,4,,,2019-04-08T13:13:03Z,,0,0,0900006483b718e4